Prothioconazole is one of the best-selling fungicides in the world and has broad room for development in the Chinese market.

Prothioconazole is a new broad-spectrum triazolethione fungicide that works by inhibiting the 14-position demethylation of the sterol precursor lanosterol in fungi. It has low toxicity, high activity, and high safety. It has the advantages of long lasting effect, wide application range, good rain resistance and good plant absorption. It is widely used in disease control scenarios of wheat, corn, rice, sugar beet, rape, peanut, beans and other crops.

Prothioconazole was first developed by Bayer CropScience and launched on the market in 2004. After the patent for the prothioconazole compound expired, international crop protection companies such as Switzerland’s Syngenta, Germany’s BASF, and Israel’s ADAMA have joined the R&D competition. road. In recent years, as the research and development process of relevant companies continues to accelerate, the total global production of prothioconazole has continued to increase. In 2022, the global production of prothioconazole technical material will exceed 9,000 tons.

At the same time, up to now, prothioconazole has been registered for use in more than 80 countries/regions around the world by virtue of its good advantages, becoming one of the best-selling fungicides in the world, and market sales continue to increase. According to the“2023-2027 China Prothioconazole Industry Market Monitoring and Future Development Prospects Research Report” released by the Industrial Research Center It shows that global sales of prothioconazole will exceed US$1.5 billion in 2022. At present, its market has entered a stage of booming supply and demand, and the industry is developing well.

From the perspective of the domestic market, the development of the prothioconazole industry continues to be favored by the dual factors of demand and policies. In terms of policy, the “14th Five-Year Plan” National Pesticide Industry Development Plan issued by the country in January 2022 clearly listed wheat stripe rust and scab as major pests and diseases affecting national food security, and listed their prevention and control drugs as necessary Pesticide varieties that continue to be stably produced and supplied; in February 2022, the National Agricultural Technology Center’s “Notice on Issuing Technical Key Points for the Prevention and Control of Major Pests and Diseases such as Wheat “Two Diseases”” listed prothioconazole as “wheat in areas where carbendazim is resistant” Optional drugs for the prevention and control of “two diseases”. Benefiting from policy support, my country’s prothioconazole industry has broad room for development.

In terms of demand, my country is the world’s largest wheat planting country. According to data from the National Bureau of Statistics, the national wheat planting area will reach 23.52 million hectares in 2022. At the same time, in recent years, the frequency of wheat scab and rust diseases in my country has continued to increase. As a result, the market demand for prothioconazole, a broad-spectrum fungicide that can effectively prevent and control wheat scab, rust, powdery mildew and other diseases, will continue to grow. It is expected that by 2024, my country’s prothioconazole market capacity will exceed 4 billion yuan.

Industry analysts said that attracted by the vast market space, my country has entered the prothioconazole market. The number of enterprises continues to increase. According to data from the China Pesticide Information Network, as of February 2023, there are 21 registered products of prothioconazole in China, including 17 single doses (including 15 original drugs) and 4 mixtures. The relevant production companies mainly include seaside products. Leer Pharmaceutical, Nantong Tahoe Chemical, Anhui Jiuyi Agriculture, Nantong Yaben Chemical, Hebei Xingbai Pharmaceutical, Ningxia Yifan Biology, Inner Mongolia Lingsheng Crops, etc.